VC fund profile · evidence-aware directory data
Oxford Science Enterprises stages, portfolio and investment profile
Independent investment company that builds and backs science and technology businesses originating from Oxford research.
Keep track of Oxford Science Enterprises
Save this profile to your VCT watchlist for a quick return.
Stage-based planning range
$1M–$10M
This is a planning range inferred from stage coverage, not a firm-disclosed check size.
Methodology: Stage bucket inferred from the rounds a fund leads or invests in.
No firm-specific check-size disclosure is recorded.
Investment stages
Leads: Seed, Series A, Series B
Participates: Seed, Series A, Series B, Growth
Sector focus
biotech-life-sciences · healthtech · deep-tech · hardware-semiconductors
Geography
Oxford, United Kingdom
Founded Not recorded
Fund size / AUM
Not recorded
A separate fund-size evidence record is not yet available.
Portfolio in our directory
3
Linked startup profiles
Recent tracked investment
Not recorded
No dated round explicitly links this fund.
Rounds they lead
Rounds they invest
Last verified: 2026-10-08T02:10:00Z. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.
Portfolio companies we track
Startups in our directory that list Oxford Science Enterprises as an investor (3 total).
- OMass Therapeutics Oxford biotech developing small-molecule medicines in endocrinology and immunology.
- Salience Labs Silicon-photonic all-optical switches for AI data-center networking.
- Sensible Biotechnologies Biotechnology company designing and manufacturing naturally modified mRNA inside engineered living cells.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.